272 related articles for article (PubMed ID: 33238613)
1. Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery.
Mansoldo FRP; Carta F; Angeli A; Cardoso VDS; Supuran CT; Vermelho AB
Molecules; 2020 Nov; 25(22):. PubMed ID: 33238613
[TBL] [Abstract][Full Text] [Related]
2. Translational challenges of animal models in Chagas disease drug development: a review.
Chatelain E; Konar N
Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
[TBL] [Abstract][Full Text] [Related]
3. Chagas Disease: A Solvable Problem, Ignored.
Tarleton RL
Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic screening approaches for Chagas disease drug discovery.
Chatelain E; Ioset JR
Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
[TBL] [Abstract][Full Text] [Related]
5. Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives.
Ogindo CO; Khraiwesh MH; George M; Brandy Y; Brandy N; Gugssa A; Ashraf M; Abbas M; Southerland WM; Lee CM; Bakare O; Fang Y
Bioorg Med Chem; 2016 Aug; 24(16):3849-55. PubMed ID: 27345756
[TBL] [Abstract][Full Text] [Related]
6. Advances in Chagas disease drug development: 2009-2010.
Buckner FS; Navabi N
Curr Opin Infect Dis; 2010 Dec; 23(6):609-16. PubMed ID: 20885320
[TBL] [Abstract][Full Text] [Related]
7. The translational challenge in Chagas disease drug development.
Kratz JM; Gonçalves KR; Romera LM; Moraes CB; Bittencourt-Cunha P; Schenkman S; Chatelain E; Sosa-Estani S
Mem Inst Oswaldo Cruz; 2022; 117():e200501. PubMed ID: 35613156
[TBL] [Abstract][Full Text] [Related]
8. Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment.
Menna-Barreto RF; de Castro SL
Curr Top Med Chem; 2017; 17(10):1212-1234. PubMed ID: 27784255
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Chagas Disease Drug Discovery: A Review.
Paucar R; Moreno-Viguri E; Pérez-Silanes S
Curr Med Chem; 2016; 23(28):3154-3170. PubMed ID: 27356544
[TBL] [Abstract][Full Text] [Related]
10. Chagas disease drug discovery: toward a new era.
Chatelain E
J Biomol Screen; 2015 Jan; 20(1):22-35. PubMed ID: 25245987
[TBL] [Abstract][Full Text] [Related]
11. Novel Diarylthioether Compounds as Agents for the Treatment of Chagas Disease.
Beveridge J; Tran E; Deora GS; Huang F; Wang Y; Stockton K; Cotillo I; Martinez Martinez MS; Gonzalez S; Castañeda P; Sherman J; Rodriguez A; Kessler A; Baell JB
J Med Chem; 2023 Jan; 66(2):1522-1542. PubMed ID: 36626662
[TBL] [Abstract][Full Text] [Related]
12. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
Ekins S; de Siqueira-Neto JL; McCall LI; Sarker M; Yadav M; Ponder EL; Kallel EA; Kellar D; Chen S; Arkin M; Bunin BA; McKerrow JH; Talcott C
PLoS Negl Trop Dis; 2015; 9(6):e0003878. PubMed ID: 26114876
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms.
Eufrásio AG; Cordeiro AT
Methods Mol Biol; 2020; 2116():773-780. PubMed ID: 32221954
[TBL] [Abstract][Full Text] [Related]
15. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.
Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ;
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery for chagas disease: A viewpoint.
Kratz JM
Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
[TBL] [Abstract][Full Text] [Related]
18. Why hasn't there been more progress in new Chagas disease drug discovery?
Vermelho AB; Rodrigues GC; Supuran CT
Expert Opin Drug Discov; 2020 Feb; 15(2):145-158. PubMed ID: 31670987
[No Abstract] [Full Text] [Related]
19. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
Maluf FV; Andricopulo AD; Oliva G; Guido RV
Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
[TBL] [Abstract][Full Text] [Related]
20. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.
Beltran-Hortelano I; Alcolea V; Font M; Pérez-Silanes S
Bioorg Med Chem; 2022 Mar; 58():116577. PubMed ID: 35189560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
